Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies

Future Med Chem. 2019 May;11(10):1177-1193. doi: 10.4155/fmc-2018-0435. Epub 2019 Feb 25.

Abstract

The pharmacophore concept is a fundamental cornerstone in drug discovery, playing a critical role in determining the success of in silico techniques, such as virtual screening and 3D-QSAR studies. The reliability of these approaches is influenced by the quality of the physicochemical descriptors used to characterize the chemical entities. In this context, a pivotal role is exerted by lipophilicity, which is a major contribution to host-guest interaction and ligand binding affinity. Several approaches have been undertaken to account for the descriptive and predictive capabilities of lipophilicity in 3D-QSAR modeling. Recent efforts encode the use of quantum mechanical-based descriptors derived from continuum solvation models, which open novel avenues for gaining insight into structure-activity relationships studies.

Keywords: 3D-QSAR; continuum solvation models; hydrophobic pharmacophore; lipophilicity; quantum mechanical-derived descriptors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Computer Simulation
  • Drug Design*
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Ligands
  • Models, Chemical
  • Pharmaceutical Preparations / chemistry*
  • Quantitative Structure-Activity Relationship*
  • Quantum Theory

Substances

  • Ligands
  • Pharmaceutical Preparations